Biohaven Pharmaceutical Holding Company Ltd. Increase (Decrease) in Restricted Cash
Biohaven Pharmaceutical Holding Company Ltd. reported Increase (Decrease) in Restricted Cash of -$127.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-06.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-06
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $0.00.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $0.00.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was -$60.00K.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was -$67.00K.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in restricted cash for fiscal 2017 was -$127.00K, a 200.00% decline from fiscal 2016.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in restricted cash for fiscal 2016 was $127.00K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $0.00 derived: sum of 2 quarters · filed 2018-03-06 | -$60.00K derived: sum of 3 quarters · filed 2018-03-06 | -$127.00K 10-K · filed 2018-03-06 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$60.00K derived: sum of 2 quarters · filed 2017-11-14 | -$127.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$127.00K 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | -$67.00K 10-Q · filed 2017-06-16 | |||
| 2016-12-31 | $127.00K 10-K · filed 2018-03-06 |